These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2769542)

  • 1. Factors affecting urea clearance during continuous hemodiafiltration in the canine model.
    Hiyama DT; Weiss RG; Ryckman FC
    J Pediatr Surg; 1989 Aug; 24(8):756-9. PubMed ID: 2769542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous venovenous hemodialysis in a neonate model: a two-pump system.
    Jouvet P; Colomer S; Jugie M; Meftali Y; Vassault A; Man NK
    Crit Care Med; 1998 Jan; 26(1):115-9. PubMed ID: 9428552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clearance of protein-bound solutes by hemofiltration and hemodiafiltration.
    Meyer TW; Walther JL; Pagtalunan ME; Martinez AW; Torkamani A; Fong PD; Recht NS; Robertson CR; Hostetter TH
    Kidney Int; 2005 Aug; 68(2):867-77. PubMed ID: 16014068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous renal replacement therapy in critically ill patients.
    Zobel G; Rödl S; Urlesberger B; Kuttnig-Haim M; Ring E
    Kidney Int Suppl; 1998 May; 66():S169-73. PubMed ID: 9573597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal replacement therapy.
    Leblanc M; Garred LJ; Cardinal J; Pichette V; Nolin L; Ouimet D; Geadah D
    Am J Kidney Dis; 1998 Sep; 32(3):444-53. PubMed ID: 9740161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of solute clearance during continuous hemofiltration, hemodiafiltration, and hemodialysis using a polysulfone hemofilter.
    Reeves JH; Butt WW
    ASAIO J; 1995; 41(1):100-4. PubMed ID: 7727810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
    Gong D; Ji D; Xie H; Xu B; Liu Y; Li L
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extrarenal elimination procedures in acute kidney failure].
    Sold M
    Anaesthesist; 1990 Nov; 39(11):569-86. PubMed ID: 2288406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of solute clearance in three modes of continuous renal replacement therapy.
    Parakininkas D; Greenbaum LA
    Pediatr Crit Care Med; 2004 May; 5(3):269-74. PubMed ID: 15115566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system.
    Lonnemann G; Floege J; Kliem V; Brunkhorst R; Koch KM
    Nephrol Dial Transplant; 2000 Aug; 15(8):1189-93. PubMed ID: 10910443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solute transport in continuous hemodialysis: a new treatment for acute renal failure.
    Sigler MH; Teehan BP
    Kidney Int; 1987 Oct; 32(4):562-71. PubMed ID: 3430952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis.
    Maxvold NJ; Smoyer WE; Custer JR; Bunchman TE
    Crit Care Med; 2000 Apr; 28(4):1161-5. PubMed ID: 10809299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoglobin clearance and removal during continuous venovenous hemofiltration.
    Amyot SL; Leblanc M; Thibeault Y; Geadah D; Cardinal J
    Intensive Care Med; 1999 Oct; 25(10):1169-72. PubMed ID: 10551978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automatic continuous venovenous hemodiafiltration in cardiosurgical patients.
    Caprioli R; Favilla G; Palmarini D; Comite C; Gemignani R; Rindi P; Cioni L
    ASAIO J; 1993; 39(3):M606-8. PubMed ID: 8268609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
    Joy MS; Matzke GR; Frye RF; Palevsky PM
    Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations.
    Lorenzin A; Garzotto F; Alghisi A; Neri M; Galeano D; Aresu S; Pani A; Vidal E; Ricci Z; Murer L; Goldstein SL; Ronco C
    Pediatr Nephrol; 2016 Oct; 31(10):1659-65. PubMed ID: 27139897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis.
    Bonnardeaux A; Pichette V; Ouimet D; Geadah D; Habel F; Cardinal J
    Am J Kidney Dis; 1992 Jan; 19(1):31-8. PubMed ID: 1739079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iohexol transmembrane clearance during modeled continuous renal replacement therapy.
    Yardman-Frank JM; Mercier RC; Wong CS; Vilay AM
    Blood Purif; 2015; 39(1-3):188-192. PubMed ID: 25765443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
    Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
    Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of elimination of pefloxacin and of its derivatives in continuous hemodiafiltration].
    Journois D; Chanu D; Ruat JM; Ballereau M; Garraffo R; Safran D
    Pathol Biol (Paris); 1991 Apr; 39(4):260-3. PubMed ID: 2062549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.